CoChat

An updated landscape on nanopharmaceutical delivery for mitigation of colon cancer

Shahzad, Maria, Hameed, Huma, Amjad, Ayesha, Khan, Mahtab Ahmad, Qureshi, Inaba Shujaat, Hameed, Anam, Saeed, Asad, Munir, Rabia · 2025 · Naunyn-Schmiedeberg's Archives of Pharmacology

The DOI matches its Crossref record; 126 of the 126 references it cites were found in a registry or an index.

Abstract

Globally, colorectal cancer (CRC) continues to rank among the leading causes of cancer-related death. Systemic toxicity, multidrug resistance, and nonspecific targeting often pose challenges to conventional therapy for CRC. Because it is a complex disease with a complex genetic and environmental pathophysiology, advanced therapeutic strategies are needed. Nanotechnology presents a potential solution that may maximize therapeutic efficacy while minimizing negative effects by enabling personalized delivery of anticancer drugs. This review focuses on recent developments in colorectal drug delivery systems based on nanotechnology. Numerous nanomaterials, including liposomes, dendrimers, micelles, exosomes, and gold nanoparticles, are developed and used. Distinctive characteristics of mentioned nanocarriers are discussed along with strategies that can be employed for enhancing the delivery of drugs to colorectal cancer cells. The review also quotes the most relevant preclinical and clinical studies that show how these nanomaterials improve drug solubility, stability, and targeted delivery while overcoming the shortcomings of conventional therapies. Nanotechnology has made CRC treatment very efficient and advanced, which has opened up new possibilities for targeted drug delivery. Preclinical and clinical studies have also proved that the use of nano-formulations in colon-specific delivery systems have significant results, indicating potential for better patient outcomes. Future res…

Overview

Integrity signals

Registry

Crossref · 10.1007/s00210-024-03482-0

Cites

126 of 126 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 126 references

Cited by

Metadata

Authors
Shahzad, M., Hameed, H., Amjad, A., Khan, M. A., Qureshi, I. S., Hameed, A., Saeed, A., & Munir, R.
Affiliations
  • University of Central Punjab (PK)
  • Lahore University of Biological and Applied Sciences (PK)
  • Riphah International University (PK)
  • Government College University, Faisalabad (PK)
Corresponding author
Hameed, Huma
Venue
Naunyn-Schmiedeberg's Archives of Pharmacology
Published
2024-10-03
Volume
398
Issue
3
Pages
2107-2125
ISSN
  • 0028-1298 (ISSN-L)
  • 1432-1912
OpenAlex
W4403106438
Cited by
7
References
126
Citations by year
2026: 4 · 2025: 3
FWCI
0.20
Type
journal article
Language
en
Open access
closed
Licence
Locations
  • Naunyn-Schmiedeberg s Archives of Pharmacology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Pharmacology and Nanomedicine Research
Keywords
colorectal cancer, colon cancer, targeted drug delivery, nanocarriers, liposomes, dendrimers, micelles, exosomes, gold nanoparticles, multidrug resistance, colon-targeted drug delivery, drug solubility and stability, biocompatibility, nanomedicine regulation
MeSH terms
Nanoparticle Drug Delivery System, Animals, Antineoplastic Agents, Colonic Neoplasms, Drug Carriers, Humans, Drug Delivery Systems, Nanotechnology

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.